Michael Jamie Hochman MD (He/Him)

Hematologic Oncology

Assistant Professor

1365 Clifton Road, NEBuilding B, Suite B4000Atlanta, GA 30322
Phone+1 404-778-5536
Fax+1 404-778-4755

Dr. Hochman is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hochman's full profile Already have an account?

Summary

Dr. Michael Hochman is an Assistant Professor of Hematology at Emory University, specializing in hematologic oncology. He completed his medical degree at Duke University School of Medicine, followed by an internal medicine residency at the University of Washington and a hematology fellowship at Johns Hopkins University. His clinical expertise focuses on acute myeloid leukemia, myeloproliferative neoplasms, and myelodysplastic syndromes. Dr. Hochman has published several research articles in esteemed journals and has received the ASH Abstract Achievement Award from the American Society of Hematology in 2022.

Clinical Expertise

Acute myeloid leukemia, Myeloproliferative neoplasms, Myelodysplastic syndromes

Education & Training

Johns Hopkins UniversityFellowship, Hematology, 2020 - 2023
University of WashingtonResidency, Internal Medicine, 2017 - 2020
Duke University School of MedicineClass of 2017

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

GA State Medical License 2023 - 2028
MD State Medical License 2021 - 2024
WA State Medical License 2019 - 2020
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

ASH Abstract Achievement Award American Society of Hematology, 2022

Publications & Presentations

PubMed

Quantitation of Cirtuvivint (SM08502) in Human Plasma by LC-MS/MS.
Julianne L Holleran, Joshua J Deppas, Ye Feng, Michael J Hochman, Evan C Chen
Biomedical Chromatography. 2026-10-01
Signaling Mutations Negate the Favorable Impact of NPM1 Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN/HMA.
Fieke W Hoff, Joshua F Zeidner, Geeta Torlapati, Deedra Nicolet, Krzysztof Mrózek
American Journal of Hematology. 2026-09-01
Phase Ib/II trial of anti-CD33 monoclonal antibody BI 836858 and azacitidine in previously untreated older acute myeloid leukemia patients: Beat AML S2 sub-study results.
Michael J Hochman, Amy S Ruppert, Ying Huang, Alice Mims, Uma Borate
Haematologica. 2026-04-23

Lectures

Does intensity of induction chemotherapy affect the impact of measurable residual disease (MRD) on prognosis in acute myeloid leukemia (AML)?
2019 ASCO Annual Meeting - 6/1/2019